Prequalified Active Pharmaceutical Ingredients
This list contains sources of active pharmaceutical ingredients (APIs) that have been assessed by WHO and found to be acceptable, in principle, for use in manufacture of finished pharmaceutical products to be procured by UN agencies.
Prequalification of APIs generally involves evaluation of data relating to their quality, as well as inspection of the relevant manufacturing site(s).
The APIs listed are those for which the submitted data and information were found to meet — at the time of assessment — WHO norms and standards, and for which the relevant manufacturing sites were found to comply — at the time of inspection — with Good Manufacturing Practices.
Some of the APIs listed have been listed on the basis of assessment and inspection carried out by stringent regulatory authorities who are willing to share information with WHO.
Displaying: 151 - 183 of 183
Download list as CSV file
WHO Product ID Sort descending | INN | Grade | Therapeutic area | Applicant | Date of prequalification | Confirmation of Prequalification Document Date |
---|---|---|---|---|---|---|
WHOAPI-419 | Medroxyprogesterone acetate - Sterile | micronised | Reproductive health | Zhejiang Xianju Pharmaceutical Co., Ltd. | ||
WHOAPI-422 | Ethionamide | Standard | Tuberculosis | Micro Labs Limited | ||
WHOAPI-423 | Carbetocin | Standard | Reproductive health | Piramal Pharma Limited | ||
WHOAPI-424 | Protionamide | Standard | Tuberculosis | Micro Labs Limited | ||
WHOAPI-427 | Albendazole | Standard | Neglected tropical diseases | Sequent Scientific Limited | ||
WHOAPI-428 | Lamivudine | Standard | HIV/AIDS | Styrax Life Sciences Pvt Ltd | ||
WHOAPI-430 | Dolutegravir (sodium) | Standard | HIV/AIDS | Emcure Pharmaceuticals Limited | ||
WHOAPI-435 | Dolutegravir (sodium) | Standard | HIV/AIDS | Aurore Life Sciences Private Limited | ||
WHOAPI-436 | Dolutegravir (sodium) | Standard | HIV/AIDS | Sun Pharmaceutical Industries Limited | ||
WHOAPI-437 | Molnupiravir | Standard | Covid-19 | Aurore Life Sciences Private Limited | ||
WHOAPI-438 | Molnupiravir | Standard | Covid-19 | Optimus Drugs Pvt Ltd | ||
WHOAPI-439 | Molnupiravir | Standard | Covid-19 | Emcure Pharmaceuticals Limited | ||
WHOAPI-442 | Bedaquiline fumarate | Standard | Tuberculosis | Lupin Manufacturing Solutions Limited | ||
WHOAPI-443 | Tranexamic acid | Standard | Reproductive health | Ami Lifesciences Private Limited | ||
WHOAPI-444 | Delamanid | Standard | Tuberculosis | Tianish Laboratories Private Limited | ||
WHOAPI-447 | Rifapentine | Standard | Tuberculosis | Lupin Ltd. | ||
WHOAPI-449 | Molnupiravir | Standard | Covid-19 | Shanghai Desano Chemical Pharmaceutical Co Ltd | ||
WHOAPI-450 | Dolutegravir (sodium) | Standard | HIV/AIDS | Styrax Pharma Pvt Ltd | ||
WHOAPI-451 | Molnupiravir | Standard | Covid-19 | Divi’s Laboratories Limited | ||
WHOAPI-457 | Molnupiravir | Standard | Covid-19 | Aurobindo Pharma Ltd | ||
WHOAPI-458 | Nirmatrelvir | Standard | Covid-19 | Zhejiang Jiuzhou Pharmaceutical Co, Ltd | ||
WHOAPI-459 | Dihydroartemisinin | Standard | Malaria | Guilin Pharmaceutical Co., Ltd. | ||
WHOAPI-464a | Nirmatrelvir | Standard | Covid-19 | Zhejiang Huahai Pharmaceutical Co. Ltd. | ||
WHOAPI-464b | Nirmatrelvir | Micronized | Covid-19 | Zhejiang Huahai Pharmaceutical Co. Ltd. | ||
WHOAPI-467 | Nirmatrelvir | Standard | Covid-19 | Zhejiang Apeloa Kangyu Pharmaceutical Co Ltd | ||
WHOAPI-469 | Nirmatrelvir | Standard | Covid-19 | Shanghai Desano Chemical Pharmaceutical Co Ltd | ||
WHOAPI-471 | Nirmatrelvir | Standard | Covid-19 | Chongqing Carelife Pharmaceutical Co., Ltd. | ||
WHOAPI-477 | Molnupiravir | standard | Covid-19 | Tianish Laboratories Private Limited | ||
WHOAPI-481a | Nirmatrelvir | Non-micronized | Covid-19 | Tianish Laboratories Private Limited | ||
WHOAPI-481b | Nirmatrelvir | Micronized | Covid-19 | Tianish Laboratories Private Limited | ||
WHOAPI-483 | Nirmatrelvir | Standard | Covid-19 | DongBang Future Tech & Life Co., Ltd. | ||
WHOAPI-507 | Rifampicin | Standard | Tuberculosis | Macleods Pharmaceuticals Ltd | ||
WHOAPI-520 | Rifampicin | Standard (Form II) | Tuberculosis | Hebei Xingang Pharmaceutical Co Ltd |
Pagination
.